Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
The aim of this study was to further elucidate the relationship between resistin and insulin sensitivity, body fat distribution and the metabolic syndrome in humans.
We measured plasma resistin levels in 177 non-diabetic subjects (75 male, 102 female; age 32–75 years). BMI, waist circumference, blood pressure, lipids, glucose, plasminogen-activator inhibitor 1 (PAI-1), adiponectin and leptin levels were also measured. The insulin sensitivity index (S I) was quantified using Bergman’s minimal model. Intra-abdominal fat (IAF) and subcutaneous fat (SQF) areas were quantified by CT scan. Presence of metabolic syndrome criteria was determined using the National Cholesterol Education Program Adult Treatment Panel III guidelines.
When subjects were divided into categories based on BMI (< or ≥27.5 kg/m2) and S I (< or ≥ 7×10−5 min−1 [pmol/l]−1), resistin levels did not differ between the lean, insulin-sensitive (n=53, 5.36±0.3 ng/ml), lean, insulin-resistant (n=67, 5.70±0.4 ng/ml) and obese, insulin-resistant groups (n=48, 5.94±0.4 ng/ml; ANOVA p=0.65). Resistin correlated with age (r=−0.22, p<0.01), BMI (r=0.16, p=0.03) and SQF (r=0.19, p=0.01) but not with S I (p=0.31) or IAF (p=0.52). Resistin did not correlate with the number of metabolic syndrome criteria or any of the individual metabolic syndrome criteria. In contrast, adiponectin, PAI-1 and leptin each correlated with IAF, SQF and S I. Additionally, the number of metabolic syndrome criteria correlated with adiponectin (r=−0.32, p<0.001), leptin (r=0.31, p<0.001) and PAI-1 (r=0.26, p=0.001).
In contrast to other adipokines, resistin is only weakly associated with body fat and is unlikely to be a major mediator of insulin resistance or the metabolic syndrome in humans.
- Steppan, CM, Bailey, ST, Bhat, S (2001) The hormone resistin links obesity to diabetes. Nature 409: pp. 307-312 CrossRef
- Azuma, K, Katsukawa, F, Oguchi, S (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11: pp. 997-1001
- Volarova de Courten, B, Degawa-Yamauchi, M, Considine, RV, Tataranni, PA (2004) High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53: pp. 1279-1284
- Heilbronn, LK, Rood, J, Janderova, L (2004) Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89: pp. 1844-1848 CrossRef
- Kershaw, EE, Flier, JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: pp. 2548-2556 CrossRef
- Carr, DB, Utzschneider, KM, Hull, RL (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: pp. 2087-2094
- Reilly, MP, Lehrke, M, Wolfe, ML, Rohatgi, A, Lazar, MA, Rader, DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: pp. 932-939 CrossRef
- Patel, L, Buckels, AC, Kinghorn, IJ (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300: pp. 472-476 CrossRef
- Lehrke, M, Reilly, MP, Millington, SC, Iqbal, N, Rader, DJ, Lazar, MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. Plos Med 1: pp. e45 CrossRef
- Shetty, GK, Economides, PA, Horton, ES, Mantzoros, CS, Veves, A (2004) Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: pp. 2450-2457
- Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
Volume 48, Issue 11 , pp 2330-2333
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Insulin resistance
- Insulin sensitivity
- Metabolic syndrome
- Plasminogen-activator inhibitor 1
- Industry Sectors
- Author Affiliations
- 1. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Veterans Affairs Puget Sound Health Care System and Harborview Medical Center, University of Washington, Seattle, WA, USA
- 4. Veterans Affairs Puget Sound Health Care System (151), 1660 S. Columbian Way, Seattle, WA, 98108, USA
- 2. Division of Maternal–Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA
- 3. Linco Research, St Charles, MO, USA